Compare GTBP & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTBP | TGHL |
|---|---|---|
| Founded | 1965 | 2020 |
| Country | United States | Singapore |
| Employees | N/A | 7 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 20.4M |
| IPO Year | 2016 | N/A |
| Metric | GTBP | TGHL |
|---|---|---|
| Price | $0.32 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 653.3K | ★ 7.2M |
| Earning Date | 05-15-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $0.27 |
| 52 Week High | $1.78 | $3.80 |
| Indicator | GTBP | TGHL |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 52.70 |
| Support Level | $0.27 | $0.33 |
| Resistance Level | $0.47 | $0.92 |
| Average True Range (ATR) | 0.03 | 0.15 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 23.12 | 35.30 |
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
The Growhub Ltd operates as the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, the company has developed a multi-faceted approach to address industry challenges. Its business currently comprises two main divisions, which are the Traceability and Authenticity Solutions and Carbon Project Development.